Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 6721 to 6735 of 7680 results

  1. Multiple myeloma - bortezomib (consolidation therapy) [ID529]

    Discontinued [GID-TAG320]

  2. Pembrolizumab with lenvatinib for untreated PD-L1-positive metastatic non-small-cell lung cancer [ID3809]

    Discontinued [GID-TA10697]

  3. Peramivir for treating influenza [ID828]

    Discontinued [GID-TA10155]

  4. Ibrutinib for untreated mantle cell lymphoma [ID1221]

    In development [GID-TA10185] Expected publication date: TBC

  5. Lung cancer (non-small cell) - afatinib [ID357]

    Discontinued [GID-TAG422]

  6. Workplace health for employees with disabilities and long-term conditions

    Discontinued [GID-PHG58]

  7. Inpatient mental health settings

    Discontinued [GID-SGWAVE0701]

  8. Betrixaban for preventing venous thromboembolism in people hospitalised for acute medical conditions [ID913]

    Discontinued [GID-TA10154]

  9. Multiple sclerosis - sativex [ID387]

    Discontinued [GID-TAG368]

  10. Furosemide micro-pump for treating oedema associated with heart failure (ID1061)

    Discontinued [GID-TA10179]

  11. Accident and emergency departments

    Discontinued [GID-SGWAVE0762]

  12. Hypercholesterolemia - mipomersen [ID524]

    Discontinued [GID-TAG437]

  13. Autologous chondrocyte implantation using 3D collagen matrix (novocart 3D) for treating articular cartilage defects of the knee [ID2707]

    In development [GID-TA10667] Expected publication date: TBC